RaQualia resumes IPO plans

RaQualia Pharma Inc. (Aichi, Japan) plans to sell 4 million shares in an IPO underwritten by Daiwa Securities and 12 other securities firms. The shares have been approved for listing on the JASDAQ Growth Market of the Osaka Securities Exchange and are expected to start trading on July 20. Previously, RaQualia planned to sell 3.7 million shares but postponed those plans in March, citing extraordinary circumstances due to the earthquake and tsunami in Northeastern Japan on March 11 (see BioCentury Extra, March 18). ...